Nexcelom Bioscience
Biotechnology company providing cell counting, image cytometry, and image analysis services.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
$260m Valuation: $260m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Nexcelom Bioscience specializes in providing advanced cell counting and analysis solutions, primarily serving the biotechnology and pharmaceutical industries. The company operates in the cell analysis market, offering products like Cellometer and Celigo, which are used for cell counting and cytometry assays. Nexcelom's business model revolves around selling these sophisticated instruments and related consumables, as well as providing support and consultation services. Revenue is generated through direct sales, service contracts, and consumable sales. The company's clients include research institutions, pharmaceutical companies, and biotech firms engaged in cell therapy development, bioprocessing, and drug discovery.
Keywords: cell counting, cell analysis, biotechnology, pharmaceuticals, Cellometer, Celigo, cytometry, cell therapy, bioprocessing, drug discovery.